CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRLCharles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Dec 30, 2026
21wMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
CRL Earnings Report
EPS Est: $2.72 | FQ end 2026-06 | Call: 2026-08-05 15:00:00
1 more catalyst beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How CRL's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s next FDA catalyst?→
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s (CRL) next tracked catalyst is a Earnings expected August 5, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CRL biotech catalysts?→
Add CRL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.